Akebia Therapeutics (AKBA) Capital Expenditures (2013 - 2026)
Akebia Therapeutics' Capital Expenditures was $1.08 million in Q2 2026, up 756.3% from $126,000 a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Capital Expenditures (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Akebia Therapeutics' Capital Expenditures was $1.29 million through Jun 30, 2026, up 770.3% year-over-year; for FY2025, it was $291,000, up 781.8% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $33,000 in FY2024, $114,000 in FY2022 (+93.2%) and $59,000 in FY2021 (-81.4%).
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q3 2019.
- Per Business Quant data, AKBA's Capital Expenditures in the three quarters before Q2 2026 was $62,000 (Q1 2026), $70,000 (Q4 2025) and $77,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | 706,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 706,000.00 |
| Jun 30, 2026 | 1.08 Mn |
| Mar 31, 2026 | 62,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2022 | 114,000.00 |
| Mar 31, 2021 | 59,000.00 |
| Dec 31, 2020 | 317,000.00 |
| Sep 30, 2020 | -45,000.00 |
| Jun 30, 2020 | 45,000.00 |
| Dec 31, 2019 | 220,000.00 |
| Sep 30, 2019 | 2.53 Mn |
| Jun 30, 2019 | 1.98 Mn |
| Mar 31, 2019 | 1.93 Mn |
| Dec 31, 2018 | 830,000.00 |
API Access
Akebia Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();